Viptinmet 50/850mg Tablets

Viptinmet 50/850mg Tablets contain two active ingredients: Vildagliptin and Metformin. This medication is primarily used for the management of type 2 diabetes mellitus to help control blood sugar levels.

Description:

Viptinmet 50/850mg Tablets are oral tablets that combine vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin, a biguanide antidiabetic agent. Vildagliptin works by increasing the levels of incretin hormones, which stimulate the release of insulin and inhibit the release of glucagon, thereby reducing blood sugar levels. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in the body.

Uses:

Viptinmet 50/850mg Tablets are prescribed for the management of type 2 diabetes mellitus in adults when diet and exercise alone are not sufficient to control blood sugar levels. It helps to lower blood sugar levels after meals and throughout the day, thereby reducing the risk of complications associated with diabetes.

Dosage and Administration:

The dosage of Viptinmet 50/850mg Tablets and the duration of treatment depend on the severity of the diabetes, response to treatment, and other medications the patient may be taking. They are typically taken orally with meals to reduce gastrointestinal side effects. The tablets should be swallowed whole with a glass of water and should not be crushed or chewed.

Precautions:

Before taking Viptinmet 50/850mg Tablets, it is important to consider the following precautions:

1. Kidney Function: Inform your healthcare provider if you have kidney problems or are undergoing dialysis, as dose adjustments may be necessary.
2. Liver Function: Use caution if you have liver disease or impaired liver function, as metformin can affect liver function tests.
3. Hypoglycemia: Monitor blood sugar levels regularly, as Viptinmet 50/850mg Tablets may increase the risk of hypoglycemia (low blood sugar levels), especially when used with other antidiabetic medications.
4. Lactic Acidosis: Metformin, one of the components of Viptinmet 50/850mg Tablets, may rarely cause a serious condition called lactic acidosis. Seek medical attention if you experience symptoms such as weakness, tiredness, muscle pain, difficulty breathing, or stomach discomfort.

Side Effects:

Common side effects of Viptinmet 50/850mg Tablets may include:

1. Gastrointestinal disturbances such as diarrhea, nausea, vomiting, and abdominal discomfort.
2. Hypoglycemia (low blood sugar levels), particularly when used with other antidiabetic medications.
3. Headache, dizziness, or fatigue.

Storage:

Store Viptinmet 50/850mg Tablets at room temperature, away from moisture and heat, and out of reach of children.

FAQ:

1. Can Viptinmet 50/850mg Tablets be used alone or in combination with other antidiabetic medications?
   • Viptinmet 50/850mg Tablets can be used alone or in combination with other antidiabetic medications, such as insulin or sulfonylureas, as prescribed by your healthcare provider.
2. How long does it take for Viptinmet 50/850mg Tablets to start working?
   • Viptinmet 50/850mg Tablets start working shortly after ingestion, with maximum effects usually seen within a few hours after taking the medication.
3. Is Viptinmet 50/850mg Tablets safe for use during pregnancy and breastfeeding?
   • Consult your healthcare provider before taking Viptinmet 50/850mg Tablets if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of the medication during pregnancy and lactation is not well established.